Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Lipodystrophy and human immunodeficiency virus infection
Shu Jan Lan
School of Nutrition and Health Sciences
Graduate Institute of Metabolism and Obesity Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lipodystrophy and human immunodeficiency virus infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Anti-Human Immunodeficiency Virus
14%
Body Mass Index
14%
Diabetes Mellitus
14%
Diet Therapy
14%
Disease
14%
Drug Therapy
28%
Drug Tolerability
14%
Dyslipidemia
14%
Epidemic
14%
Exercise Therapy
14%
Hormone Therapy
14%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
100%
Hyperglycemia
14%
Immune Deficiency
42%
Immunity Hormone
14%
Insulin Resistance
14%
Lipectomy
14%
Lipodystrophy
100%
Liposuction
14%
Nonnucleoside Reverse Transcriptase Inhibitor
14%
Plastic Surgery
14%
Prevalence
14%
Proteinase Inhibitor
14%
Public Health
14%
Reverse-Transcriptase Inhibitor
14%
Side Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Human Immunodeficiency Virus
14%
Diabetes Mellitus
14%
Disease
14%
Drug Tolerability
14%
Dyslipidemia
14%
Epidemic
14%
HIV
100%
Hormone Cancer Therapy
14%
Human Immunodeficiency Virus Infection
100%
Hyperglycemia
14%
Immune Deficiency
42%
Insulin Resistance
14%
Lipodystrophy
100%
Nonnucleoside Reverse Transcriptase Inhibitor
14%
Pharmacotherapy
28%
Prevalence
14%
Proteinase Inhibitor
14%
RNA Directed DNA Polymerase Inhibitor
14%
Side Effect
14%